Neotison 200 Convicap

• Asthma prophylaxis: Once-daily maintenance treatment as prophylactic therapy in patients aged 5 years and older.
• Not indicated for the relief of acute bronchospasm.

Fluticasone Furoate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It utilises a fluorocarbothioate ester linkage that provides potent vasoconstrictive and anti-inflammatory activity, but weak HPA inhibitory effect when applied topically.

Adults and Adolescents Aged 12 Years and Older:

• Starting dose: 100 mcg once daily.
• May increase to 200 mcg after 2 weeks if no response.
• Maximum: 200 mcg/day.

Pediatric Patients Aged 5 to 11 Years:

• 50 mcg once daily.

Hepatic Impairment:

• Mild: No dosage adjustment required.
• Moderate-to-severe: Caution advised.

* Use as directed by the registered physician

Common Side Effects (≥5%):

• Nasopharyngitis
• Bronchitis
• Upper respiratory tract infection
• Headache

Pediatric (≥3%):

• Pharyngitis
• Bronchitis
• Viral infection

Use in Pregnancy: May be unsafe during pregnancy. Animal studies have shown harmful effects. Your doctor will weigh the benefits and risks.

Precautions:

• Do not use in acute asthma attacks (fast-acting bronchodilator needed).
• Seek medical advice if asthma symptoms remain uncontrolled or worsen.
• Paradoxical bronchospasm may occur - use bronchodilator immediately and discontinue.
• Avoid in patients with severe allergy to milk protein.

Overdose: Limited information available on overdose. Employ usual supportive measures.

Storage: Store at a temperature not exceeding 30°C. Do not refrigerate. Protect from light and moisture.